Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals
Authors:
- 1 March 2015
- journal article
- Published by Elsevier in Biologicals
- Vol. 43 (2) , 92-99
Abstract
No abstract availableKeywords
Funding Information
- European Community's Seventh Framework (FP7/2007-2013, 227003 CP-FP)
This publication has 11 references indexed in Scilit:
- Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypesVeterinary Microbiology, 2013
- CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responsesVeterinary Research, 2013
- Extraneous agent detection in vaccines − A review of technical aspectsBiologicals, 2012
- Disease severity declines over time after a wild boar population has been affected by classical swine fever—Legend or actual epidemiological process?Preventive Veterinary Medicine, 2012
- Comparative studies on the pathogenicity and tissue distribution of three virulence variants of classical swine fever virus, two field isolates and one vaccine strain, with special regard to immunohistochemical investigationsActa Veterinaria Scandinavica, 2008
- An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virusVirology, 2004
- Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strainsVeterinary Microbiology, 2000
- Introduction to classical swine fever: virus, disease and control policyVeterinary Microbiology, 2000
- Incidence and control of CSF in wild boar in EuropeVeterinary Microbiology, 2000
- Pestiviruses isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase chain reaction and restriction endonuclease analysisArchives of Virology, 1994